CA2084334A1 - Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same - Google Patents

Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same

Info

Publication number
CA2084334A1
CA2084334A1 CA002084334A CA2084334A CA2084334A1 CA 2084334 A1 CA2084334 A1 CA 2084334A1 CA 002084334 A CA002084334 A CA 002084334A CA 2084334 A CA2084334 A CA 2084334A CA 2084334 A1 CA2084334 A1 CA 2084334A1
Authority
CA
Canada
Prior art keywords
group
substituted
salt
groups
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002084334A
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Imaizumi
Tetsuya Kajita
Kenichi Takashima
Minako Yotsuji
Keiko Takakura
Akira Yotsuji
Junichi Mitsuyama
Katsumi Shimizu
Hiroshi Sakai
Hirokazu Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2084334A1 publication Critical patent/CA2084334A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002084334A 1991-12-09 1992-12-02 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same Abandoned CA2084334A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP03-350318 1991-12-09
JP35031891 1991-12-09
JP29396192A JP3471831B2 (ja) 1991-12-09 1992-10-08 新規なトリアゾール誘導体およびその塩
JP04-293961 1992-10-08

Publications (1)

Publication Number Publication Date
CA2084334A1 true CA2084334A1 (en) 1993-06-10

Family

ID=26559630

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084334A Abandoned CA2084334A1 (en) 1991-12-09 1992-12-02 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same

Country Status (7)

Country Link
US (2) US5366989A (enExample)
EP (1) EP0546529A1 (enExample)
JP (1) JP3471831B2 (enExample)
KR (1) KR100242397B1 (enExample)
AU (1) AU655089B2 (enExample)
CA (1) CA2084334A1 (enExample)
TW (1) TW225476B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
ES2062941B1 (es) * 1993-03-15 1995-10-01 Uriach & Cia Sa J Nuevos derivados de azol activos por via oral.
ES2159676T3 (es) * 1995-12-22 2001-10-16 Ss Pharmaceutical Co Derivados de triazol con actividad antimicotica e intermediarios.
US6002028A (en) * 1995-12-22 1999-12-14 Ss Pharmaceutical Co., Ltd. Triazole derivative, preparation process thereof and pharmaceutical comprising the same as an effective ingredient
US5939448A (en) * 1996-06-21 1999-08-17 Ss Pharmaceutical Co., Ltd. Triazole derivative or salt thereof
US5965188A (en) * 1996-07-31 1999-10-12 Anitox Corporation Anti-bacterial amine derivatives
DK1399402T3 (da) * 2001-06-26 2010-11-15 Basilea Pharmaceutica Ag Intermediære halophenylderivater og deres anvendelse i en fremgangsmåde til fremstilling af azolderivater
JP2006182765A (ja) * 2004-11-30 2006-07-13 Sumitomo Chemical Co Ltd エポキシトリアゾール誘導体の製造方法
WO2006059759A1 (ja) * 2004-11-30 2006-06-08 Sumitomo Chemical Company, Limited エポキシトリアゾール誘導体の製造方法
EP2440518B1 (de) * 2009-06-08 2014-08-20 Bayer Cropscience AG Verfahren zur herstellung von fluoralkylnitrilen
US20150246898A1 (en) * 2012-09-12 2015-09-03 Dow Agrosciences Llc Metalloenzyme inhibitor compounds
CN102993052B (zh) * 2012-12-29 2014-07-09 吉首大学 芳基丙酰氧肟酸类尿素酶抑制剂及其合成和用途
CN103012207B (zh) * 2012-12-29 2015-05-27 吉首大学 二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
WO2023243700A1 (ja) * 2022-06-17 2023-12-21 シンクレスト株式会社 ジフルオロアルデヒド、エポキシ及びその誘導体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616027A (en) * 1982-08-14 1986-10-07 Pfizer Inc. Antifungal 1-aryl-1-fluoroalkyl-2-(1H-1,2,4-triazol-1-yl)ethanols
PH19347A (en) * 1982-09-30 1986-04-02 Pfizer Triazole derivatives,pharmaceutical composition containing same and method of use thereof
DE3378764D1 (en) * 1982-09-30 1989-02-02 Pfizer Ltd Triazole anti-fungal agents
GB8312624D0 (en) * 1983-05-07 1983-06-08 Pfizer Ltd Triazole antifungal agents
BG48681A3 (bg) * 1982-12-14 1991-04-15 Ciba - Geigy Ag Фунгицидно средство
DE3461637D1 (en) * 1983-02-16 1987-01-22 Pfizer Ltd Triazole antifungal agents
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
GB8305377D0 (en) 1983-02-25 1983-03-30 Pfizer Ltd Antifungal agents
US4518604A (en) * 1983-07-25 1985-05-21 Pfizer Inc. Antifungal 1-aryl-2-(1H-1,2,4-triazol-1yl)-1-perfluoroalkylethyl halides
GB8322983D0 (en) * 1983-08-26 1983-09-28 Pfizer Ltd Triazole antifungal agents
GB8601952D0 (en) * 1986-01-28 1986-03-05 Ici Plc Heterocyclic compounds
DE3736773A1 (de) * 1987-10-30 1989-05-11 Bayer Ag 3-(4-chlorphenyl)-2,2-dimethyl-3-hydroxy-4- (1,2,4-triazol-1-yl)-butyronitril
KR910700237A (ko) * 1989-01-23 1991-03-14 리챠드 지. 워터맨 치환된 트리아졸, 그의 제조방법 및 살진균제로서 사용하기 위한 조성물
DE59108565D1 (de) * 1990-08-09 1997-04-03 Bayer Ag Halogenalkyl-azolyl-Derivate
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩

Also Published As

Publication number Publication date
KR100242397B1 (ko) 2000-03-02
AU2985892A (en) 1993-07-01
JP3471831B2 (ja) 2003-12-02
TW225476B (enExample) 1994-06-21
EP0546529A1 (en) 1993-06-16
JPH05213906A (ja) 1993-08-24
US5366989A (en) 1994-11-22
US5605921A (en) 1997-02-25
AU655089B2 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
RU2095358C1 (ru) Производные 1,2,4-триазола или их фармацевтически приемлемые соли, фармацевтическая композиция и промежуточные соединения
EP0567982B1 (en) Azole compounds, their production and use
CA2084334A1 (en) Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same
CA2388320C (en) N-substituted carbamoyloxyalkyl-azolium derivatives
US7189858B2 (en) N-phenyl substituted carbamoyloxyalkyl-azolium derivatives
IE42064B1 (en) Triazole derivatives and their use as anti-microbial and plant-growth regulating agents
LU88778I2 (fr) Anastrozole optionellement sous forme d'un sel d'addition d'acide pharmaceutiquement acceptable (Arimidex (R))
US6300353B1 (en) Azoles for treatment of fungal infections
IE57003B1 (en) Alpha,alpha-disubstituted 1h-azole ethanols and their use as fungicidal agents or as pharmaceuticals
HU219212B (en) Azole compounds, pharmaceutical compositions containing them and process for the preparation of these compounds
CZ415597A3 (cs) Triazolové sloučeniny, způsoby a meziprodukty pro jejich výrobu a farmaceutické prostředky na jejich bázi a jejich použití
RU2146250C1 (ru) Триазоловые соединения или их фармакологически приемлемые соли и противогрибковая композиция
EP0115400B1 (en) Triazole antifungal agents
US4933339A (en) (2-cyano-2-arylethyl)pyridine compounds useful in controlling fungicidal activity
EP1951705A1 (en) Novel antifungal triazole derivatives
CA2076404A1 (en) Fungicidal 2-aryl-2-cyano-2 (heterocyclylalkyl)ethyl-1,2,4- triazoles
IE862169L (en) (2-cyano-2-arylethyl) pyridines
WO2001072743A1 (en) Triazole compounds having amide linkage
US4343801A (en) 1,2,4-Triazine derivatives, and their production and use
JP2887523B2 (ja) 新規なトリアゾール誘導体およびその塩
AU726495B2 (en) N-benzylazolium derivatives
MXPA04010066A (es) Derivados de tetrahidrofurano 2,2,4-trisubstituido como agentes antifungicos.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued